KEVIN CHIAPPONE: Open Payments
NPI 1144645466 · CORVALLIS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 17 payments from 10 companies in 2025. Trend: 2023 $228 · 2024 $987 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| TOLMAR, INC. | 3 | $90 |
| Sumitomo Pharma America, Inc. | 3 | $85 |
| UROGEN PHARMA, INC. | 2 | $62 |
| ConvaTec Inc. | 2 | $55 |
| Boston Scientific Corporation | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Procept Biorobotics Corporation | 1 | $25 |
| Ambu Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $22 |
Products named: GEMTESA, JATENZO, GENTLECATH GLIDE, Axonics, ELIGARD, JOURNAVX, BOTOX, AQUABEAM ROBOTIC SYSTEM.
Industry payments across OR — which companies pay providers there.
